Specifically, ZEB2-AS1 overlaps with the intron of the ZEB2 5′ UTR, in which contains an IRES, enhancing the translation efficiency of ZEB2, a transcriptional suppressor of E-cadherin, and consequently leading to the downregulation of E-cadherin in breast cancer [68]. The gene discussed is ZEB2; the disease is breast cancer.